Previous Article | Next Article 
Infection and Immunity, May 1999, p. 2266-2276, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Membrane Topology and Cellular Location of the Treponema
pallidum Glycerophosphodiester Phosphodiesterase (GlpQ)
Ortholog
Dmitriy V.
Shevchenko,1
Timothy J.
Sellati,1
David L.
Cox,2
Olga V.
Shevchenko,1
Esther J.
Robinson,1 and
Justin
D.
Radolf1,3,*
Departments of Internal
Medicine1 and
Microbiology,3 University of Texas
Southwestern Medical Center, Dallas, Texas 75235, and
Division of STD Laboratory Research, Centers for Disease
Control and Prevention, Atlanta, Georgia 303332
Received 13 November 1998/Returned for modification 7 January
1999/Accepted 1 February 1999
 |
ABSTRACT |
Recent reports that isolated Treponema pallidum outer
membranes contain an ortholog for glycerophosphodiester
phosphodiesterase (GlpQ) (D. V. Shevchenko, D. R. Akins,
E. J. Robinson, M. Li, O. V. Shevchenko, and J. D. Radolf, Infect. Immun. 65:4179-4189, 1997) and that this protein is a
potential opsonic target for T. pallidum (C. E. Stebeck, J. M. Shaffer, T. W. Arroll, S. A. Lukehart,
and W. C. Van Voorhis, FEMS Microbiol. Lett. 154:303-310, 1997)
prompted a more detailed investigation of its physicochemical properties and cellular location. [14C]palmitate
radiolabeling studies of a GlpQ-alkaline phosphatase fusion expressed
in Escherichia coli confirmed the prediction from DNA
sequencing that the protein is lipid modified. Studies using
Triton X-114 phase partitioning revealed that the protein's amphiphilicity is due to lipid modification and that a
substantial portion of the polypeptide is associated with the
T. pallidum peptidoglycan sacculus. Three different
approaches, i.e., (i) proteinase K treatment of intact treponemes,
(ii) indirect immunofluorescence analysis of treponemes encapsulated in
agarose beads, and (iii) opsonophagocytosis of treponemes incubated
with antiserum against recombinant GlpQ by rabbit peritoneal
macrophages, confirmed that GlpQ is entirely subsurface in T. pallidum. Moreover, rabbits hyperimmunized with GlpQ were not
protected against intradermal challenge with virulent
treponemes. Circular dichroism spectroscopy confirmed that the
recombinant form of the polypeptide lacked discernible evidence of
denaturation. Finally, GlpQ was not radiolabeled when T. pallidum outer membranes were incubated with
3-(trifluoromethyl)-3-(m-[125I]iodophenyl)-diazarene,
a photoactivatable, lipophilic probe which promiscuously labels both
proteins and lipids within phospholipid bilayers. Taken as a
whole, these studies indicate that the T. pallidum GlpQ
ortholog is a periplasmic protein associated predominantly with the
spirochete's peptidoglycan-cytoplasmic membrane complex.
 |
INTRODUCTION |
Syphilis, a sexually transmitted
disease caused by the spirochetal pathogen Treponema
pallidum subsp. pallidum, begins as an ulcer (chancre)
at the site of inoculation (usually in the genital area) and,
when untreated, may progress through secondary (disseminated), latent, and tertiary (recrudescent) stages
(61). Despite the availability of effective antimicrobial
therapy since the 1940s, syphilis remains a global public health
problem (40, 44). Most recently, genital ulcers caused by
syphilis have been shown to facilitate the sexual transmission of human
immunodeficiency virus (24, 63). These epidemiological
trends underscore the importance of vaccine development as a
cornerstone of strategies to curtail syphilis transmission.
Unfortunately, the identification of vaccine candidates has
been impeded by a number of factors, most notably the inability to
cultivate T. pallidum on artificial medium and the syphilis
spirochete's unusual outer membrane ultrastructure (50).
In recent years, the quest for outer membrane (OM) proteins of
T. pallidum as potential virulence determinants and vaccine candidates has become a major focus of syphilis research
(50). In this regard, we recently reported that OMs
isolated from T. pallidum by using a plasmolysis-based
procedure contain a 38.5-kDa putative lipoprotein with sequence
relatedness to glycerophosphodiester phosphodiesterase (GlpQ)
(56), an enzyme which hydrolyzes deacylated phospholipids to
alcohol plus glycerol-3-phosphate (37, 39). Although GlpQ
is periplasmic in Escherichia coli (37),
the Haemophilus influenzae ortholog is surface exposed and
capable of inducing bactericidal antibodies (29, 55).
Consistent with this, Stebeck and coworkers reported
that the treponemal ortholog is a potential opsonic target for
motile T. pallidum (60). These findings
prompted a detailed investigation of the physicochemical properties
and cellular location of this protein. Here we report that, as with GlpQ of H. influenzae, the T. pallidum GlpQ
protein is lipid modified but that, unlike its H. influenzae counterpart, the treponemal polypeptide has a
subsurface location. Similar to other treponemal lipoprotein immunogens, GlpQ appears to be associated predominantly with the peptidoglycan-cytoplasmic membrane (CM) complex.
Moreover, contrary to the recent report by Cameron et al.
(16) demonstrating attenuated lesion development
when GlpQ-immunized rabbits were intradermally inoculated with virulent
T. pallidum, we did not observe any evidence of protective
immunity in GlpQ-hyperimmunized rabbits. These results are consistent
with the antigen's lack of surface exposure and suggest that GlpQ will
play a limited role in the development of a syphilis vaccine.
 |
MATERIALS AND METHODS |
Bacterial strains.
T. pallidum (Nichols) was
propagated by intratesticular inoculation of adult New Zealand
White rabbits as previously described (52). Spirochetes were
separated from testicular tissue debris by low-speed centrifugation
(350 × g for 10 min) and, when necessary, purified by
Percoll density gradient centrifugation (30). For opsonophagocytosis assays, organisms were extracted from infected testes in medium 199 (M199) (Mediatech, Herndon, Va.) supplemented with
20% heat-inactivated fetal bovine serum (HIFBS) (heated for 30 min at
56°C) (Mediatech) and gassed with 3% O2-5%
CO2 overnight at 37°C. Spirochetes were enumerated by
dark-field microscopy with a Petroff-Hausser counting chamber (Hausser
Scientific Company, Horsham, Pa.). E. coli DH5
was the
recipient strain for all recombinant constructs and was grown in
Luria-Bertani broth with appropriate antibiotic supplementation.
Production and purification of a recombinant, nonlipidated GlpQ
(rGlpQ).
The portion of the glpQ gene encoding
the mature (i.e., processed) protein was PCR amplified from
T. pallidum genomic DNA by using the forward and
reverse primers 5'-GCGGGATCCTGTGCGTCCGAACGTATGATAGTTG-3' (BamHI site plus nucleotides 61 to 85) and
5'-GCGGAATTCTCAATAGCGGGCGGGTTTGCCC-3' (complementary to
nucleotides 1049 to 1071 plus EcoRI site), respectively (56). The amplified product was cloned into pProEX-HTb
(Gibco BRL, Gaithersburg, Md.) to generate a polyhistidine (His)-tagged fusion protein. The IPTG
(isopropyl-
-D-thiogalactopyranoside)-inducible fusion
protein (designated rGlpQ-His) was purified from E. coli cell supernatant on an Ni-nitrilotriacetic acid agarose matrix (Qiagen,
Inc., Santa Clarita, Calif.) according to the manufacturer's instructions. The His tag was removed by digestion with recombinant tobacco etch virus protease (Gibco BRL) as described by the manufacturer.
Immunologic reagents.
Immune rabbit sera (IRS) were obtained
approximately 10 months following intratesticular inoculation of
rabbits with motile T. pallidum. Normal rabbit serum
(NRS) was obtained from animals that were nonreactive in Venereal
Disease Research Laboratory and fluorescent treponemal antibody tests
and was filter sterilized. A pool of normal human sera was created by
combining equal volumes of sera from five healthy adult volunteers. A
pool of human syphilitic sera (HSS) was created by combining sera from
five human immunodeficiency virus-seronegative individuals with
classical dermatological manifestations of secondary syphilis and
reactive nontreponemal and treponemal serological tests.
Rat anti-rGlpQ antiserum was generated by priming 6-week-old
Sprague-Dawley rats by intraperitoneal injection with 30 µg of purified, cleaved protein in a 1:1 mixture of
phosphate-buffered saline (PBS) (pH 7.4) and complete Freund's
adjuvant; 1 month and 6 weeks later, the animals received 15-µg
booster doses in a 1:1 mixture of PBS and incomplete Freund's
adjuvant. Rabbit anti-rGlpQ antisera were generated by immunizing adult
New Zealand White rabbits subcutaneously with 100 µg of protein
in a 1:1 mixture of PBS and complete Freund's adjuvant; 1 month
and 6 weeks later, the animals were boosted with 50 µg of protein
in incomplete Freund's adjuvant. A murine monoclonal antibody specific
for E. coli alkaline phosphatase (PhoA) was obtained from
Caltag Laboratories (Burlingame, Calif.). Rabbit antisera directed
against T. pallidum endoflagella (TpEf) (34)
and native 47-kDa lipoprotein (Tp47) (22) were described previously.
To affinity purify anti-GlpQ antibodies from IRS, 80 µg of rGlpQ was
coupled to 100 µl of 1,1'-carbonyldiimidazole-activated 6%
cross-linked beaded agarose (Reacti-Gel 6×; Pierce, Rockford, Ill.)
according to the manufacturer's instructions. The Reacti-Gel matrix
was equilibrated with 250 mM Tris (pH 7.4) and incubated for 2 h
at 4°C with 250 µl of IRS. The adsorbed anti-GlpQ antibodies were
eluted from the matrix in 200-µl fractions with 0.5 M acetic acid and
neutralized with 100 µl of 1 M Tris base. Both the anti-GlpQ and the
resulting IRS depleted of anti-GlpQ antibodies were tested by Western
blot analysis for their ability to recognize the native GlpQ (nGlpQ)
protein in T. pallidum lysates as described above. To quantitatively remove immunoglobulin G (IgG) antibodies from IRS,
IRS was passed over a GammaBind G Sepharose matrix (Pharmacia Biotech,
Alameda, Calif.). The adsorbed IgG antibodies were eluted in 500-µl
fractions with 0.5 M acetic acid and neutralized with 0.25 ml of 1 M
Tris base. The protein concentrations of the affinity-purified anti-GlpQ antibodies and total IgG fractions were determined with the
Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, Calif.).
SDS-polyacrylamide gel electrophoresis (SDS-PAGE), immunoblot
analysis, and two-dimensional gel electrophoresis.
Samples were
boiled for 5 min in final sample buffer and subjected to
electrophoresis through sodium dodecyl sulfate (SDS)-12.5% polyacrylamide gels as previously described (56). Gels were stained with either Coomassie brilliant blue or silver or transferred electrophoretically to 0.2-µm-pore-size nitrocellulose (Schleicher and Schuell, Keene, N.H.) for immunoblotting. Immunoblots were incubated with various dilutions of HSS, rabbit or rat anti-rGlpQ antisera, affinity purified anti-nGlpQ antibodies, or IRS depleted of
anti-GlpQ antibodies, followed by incubation with 1:1,000 dilutions of
horseradish peroxidase-conjugated goat anti-human, -rabbit, or -rat
immunoglobulins (Zymed Laboratories, Inc., South San Francisco, Calif.). Blots were developed by using 4-chloro-1-naphthol as a
substrate. Two-dimensional gel electrophoresis was performed according
to the method of O'Farrell (43).
Enzyme-linked immunosorbent assay.
An Immulon II 96-well
U-bottom plate (Dynatech, Chantilly, Va.) was coated with 25 ng of
rGlpQ in 0.1 M Na2CO3 buffer (pH 9.4) per well
and incubated overnight at 4°C. The wells were washed four times with
PBS containing 0.05% Tween 20 and blocked with PBS containing 1%
bovine serum albumin (BSA) (Sigma Chemical Company, St. Louis, Mo.) for
2 h at 37°C. To the wells were added HSS, IRS, affinity purified
anti-GlpQ antibodies, and IRS depleted of anti-GlpQ antibodies serially
diluted in PBS containing 1% BSA plus 0.05% Tween 20. Following
incubation for 1 h at 37°C, the wells were washed four times,
followed by the addition of a 1:1,000 dilution of goat anti-human, goat
anti-rat, or goat anti-rabbit IgG (Zymed)-horseradish peroxidase
conjugate. After incubation for 1 h at 37°C, the wells were
washed four times and incubated for 20 min at room temperature with TMB
peroxidase substrate (Kirkegaard & Perry Laboratories, Gaithersburg,
Md.). The reaction was quenched by addition of 2 N
H2SO4, and the optical densities in the wells
were read immediately at 450 nm.
Glycerophosphodiester phosphodiesterase assay.
The enzymatic
activity of rGlpQ was examined at 25°C by measuring
glycerol-3-phosphate production in a coupled spectrophotometric assay
performed as described by Larson et al. (37) with minor modifications. The 1-ml assay mixture contained 0.9 ml of 1 M hydrazine
hydrate in 1.5% glycine buffer (pH 9.0), 0.5 mM NAD, 10 mM
CaCl2, 20 U of glycerol-3-phosphate dehydrogenase/ml, and one of the following substrates at 0.5 mM: glycerophosphorylcholine, glycerophosphorylethanolamine, glycerophosphorylserine, or
glycerophosphorylinositol (all purchased from Sigma).
Glycerophosphorylcholine phosphodiesterase (Sigma catalog no. G1642)
and glycerophosphorylcholine were used as a positive control. The rate
of NAD reduction was measured by recording the increase in absorbance
at 340 nm. One unit of phosphodiesterase activity is defined as the
amount of enzyme required to hydrolyze 1 µmol of
glycerophosphodiester min
1 under these conditions. A
molar absorbance coefficient of 6,300 M
1
cm
1 at 340 nm was used for NADH.
CD spectroscopy.
Circular dichroism (CD) spectra were
obtained on an AVIV (Lakewood, N.J.) model 62DS spectropolarimeter with
sample temperatures regulated by a Hewlett-Packard model 89100A
temperature controller; measurements were taken at 25 ± 0.1°C.
CD spectra were obtained with 4 µM samples of rGlpQ or recombinant
gonococcal porin P1A (25). CD spectroscopic analysis of
rGlpQ was performed with 10 mM phosphate buffer (pH 7.3) with or
without 5 mM EDTA and also with 10 mM phosphate buffer containing 0.5%
SDS,
0.5% CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate}, or 0.6%
octylglucoside. CD spectra were obtained for the recombinant gonococcal
porin P1A in 10 mM phosphate buffer (pH 7.3) containing 0.6%
octylglucoside. All CD spectra were baseline corrected and smoothed
with software provided by AVIV Associates. The self-consistent algorithm of Sreerama and Woody (58, 59) was used to
calculate the percentages of various types of secondary structures.
Triton X-114 phase partitioning.
Percoll-purified
T. pallidum (5 × 109 organisms) was
solubilized overnight in 1 ml of PBS containing 2% Triton X-114. The
insoluble material was then removed by centrifugation for 15 min in a
microcentrifuge, and the supernatant was phase separated as previously
described (12, 15, 52). rGlpQ was subjected to phase
partitioning under identical conditions. The proteins in the
aqueous and detergent phases were concentrated by acetone precipitation
prior to SDS-PAGE.
[14C]palmitate labeling of a GlpQ-PhoA fusion
protein.
The primers
5'-TCTAGTCTAGAAGAATGCTTGCGTGTGGCGAAGG-3' (XbaI
site plus nucleotides
399 to
365) and
5'-GCGGGATCCGTGCTCGGGCACATATCCTGCAGC-3' (complementary to
nucleotides 96 to 120 plus BamHI site), were used to
generate a 519-bp PCR product which encoded the first 40 amino acids of
GlpQ plus upstream flanking DNA (including the putative promoter). The
resulting amplicon was cloned upstream from and in frame with the
E. coli alkaline phosphatase gene (phoA) lacking
the leader peptide by using the previously described vector pSKI/pho
(1). Single colonies of E. coli DH5
containing
the resulting plasmid (designated pGlpQ-Pho), along with control
plasmids expressing PhoA fusions with the N terminus of LacZ
(1) and the N terminus of Tp47 (64), were
inoculated into 30-ml portions of one-half-strength Luria-Bertani broth
containing ampicillin (100 µg/ml) and grown to an optical density at
600 nm of 0.1. Fifteen microcuries of [U-14C]-palmitic
acid (500 mCi/mmol; New England Nuclear, Boston, Mass.) was added to
each culture. The cultures were then incubated with shaking to an
optical density at 600 nm of 0.6, after which they were harvested and
washed twice with PBS prior to SDS-PAGE, immunoblot analysis, and autoradiography.
Nucleotide sequence analysis.
Nucleotide sequencing of
the various fusion constructs was performed with an Applied
Biosystems Inc. (Foster City, Calif.) model 373A automated DNA
sequencer and the PRISM ready-reaction DyeDeoxy Terminator cycle
sequencing kit according to the manufacturer's instructions.
Accessibility of nGlpQ to digestion with PK.
The
accessibility of nGlpQ to digestion with proteinase K (PK) was
determined as described by Barbour et al. (8). Freshly isolated T. pallidum organisms (5 × 109) were centrifuged at 20,000 × g for 15 min and resuspended in 0.1 ml of PBS containing 5 mM MgCl2.
PK was added to a final concentration of 0.4 mg/ml, and the spirochetes
were incubated at room temperature for 30 min. Proteolytic digestion
was stopped by the addition of phenylmethylsulfonyl fluoride to a final
concentration of 1 mg/ml. Lysates of PK-treated and untreated
T. pallidum were processed for SDS-PAGE and immunoblot
analysis as described above.
Localization of nGlpQ by indirect immunofluorescence of
T. pallidum encapsulated in gel microdroplets.
T. pallidum cell suspensions were encapsulated in gel
microdroplets as previously described (21). Encapsulated
organisms were probed with specific antibodies by a three-step indirect immunofluorescence technique. Briefly, rat anti-rGlpQ serum was diluted
1:20 and added directly to small aliquots of beads (0.3 to 0.4 ml) in 1 ml of T. pallidum cultivation medium. In samples incubated with detergent, a 1% (vol/vol) Triton X-100 stock solution in PBS was added to the beads immediately after the addition of the
primary antibody to produce a final concentration of 0.05% (vol/vol).
Samples were incubated for 2 h with gentle mixing in a 34°C
water bath. The beads were washed three times by low-speed centrifugation (100 × g), resuspended in 3 ml of
T. pallidum culture medium (23), and then
incubated for 1 h at 34°C with mouse anti-rat IgG. Beads were
washed as described above, resuspended in 3 ml of T. pallidum culture medium, and incubated for 1 h at 34°C with 3 µg of goat anti-mouse IgG coupled to R-phycoerythrin
(Molecular Probes, Eugene, Oreg.). The beads were washed a final time
and then viewed on glass slides with a Nikon Optiphot-2 fluorescence microscope equipped with 15× oculars, a dark-field condenser, and a
fluorescein filter. Samples were observed with either a 40× or a 100×
oil immersion objective. For each condition (i.e., antibody and
detergent concentration) three slides were prepared, and then
approximately 100 organisms were scored for labeling (fluorescence).
Statistical comparisons with the preimmune sera were performed by using
a two-tailed Student t test; P values of
0.5
were considered significant.
Opsonophagocytosis assay for surface exposure of
nGlpQ.
Opsonophagocytosis assays were performed as described by
Baker-Zander et al. (4-6). Rabbit peritoneal macrophages
were elicited by intraperitoneal injection of 10 ml of 15% sterile
Proteose Peptone no. 3 (Difco Laboratories, Detroit, Mich.). Cells were harvested at 3 to 5 days postinjection by peritoneal lavage with FA
buffer (Difco) containing 10 U of heparin (Sigma) per ml, centrifuged at 900 × g for 10 min, and resuspended in M199
supplemented with 20% HIFBS (Mediatech), 100 U of penicillin/ml, and
100 µg of streptomycin/ml (M199-complete). They then were counted
with a hemacytometer and dispensed into 24-well cluster tissue culture
plates containing 12-mm-diameter microscope coverslips (catalog no.
12-545-82; Fisher Scientific, Pittsburgh, Pa.) at a density of 5 × 105 cells/ml. After incubation for 2 h at 37°C,
nonadherent cells were removed by washing the adherent monolayers twice
with M199-complete. The cells were maintained overnight at 37°C in a
reduced-oxygen atmosphere containing 3% O2 and 5%
CO2. The following day, the adherent macrophages were
washed twice with gassed M199-complete. The cells were then incubated
for 4 h at 37°C in a reduced-oxygen atmosphere (3%
O2 and 5% CO2) with T. pallidum (10 organisms per macrophage) in the presence of 20%
HIFBS plus 10% heat-inactivated (56°C for 30 min) NRS, IRS, rabbit
anti-rGlpQ, rabbit anti-TpEf, or rabbit anti-Tp47. In separate
reconstitution experiments, the opsonic activities of affinity-purified
anti-GlpQ antibodies, IgG antibodies from IRS, and IRS depleted of
either anti-GlpQ or total IgG antibodies were evaluated. The
affinity-purified antibodies were added to the wells in amounts
equivalent to those recovered from 100 µl of IRS. Following
incubation with T. pallidum, coverslips were washed
twice with serum-free M199 medium and fixed for 15 min in 95% ethanol.
Fixed cells on coverslips were rehydrated with PBS containing 1% BSA
for 10 min at room temperature or stored overnight at 4°C.
To visualize T. pallidum, the cells were blocked
for 30 min at room temperature with CMRL medium containing 10% HIFBS
and then incubated for 1 h at room temperature with HSS diluted
1:100 in CMRL plus 10% HIFBS. Coverslips were washed three times with FA buffer and blocked for 30 min at room temperature with CMRL plus
10% HIFBS. After blocking, cells were incubated for 30 min at room
temperature with goat anti-human IgG conjugated to fluorescein isothiocyanate (Zymed) diluted 1:1,000 in CMRL plus 10% HIFBS. Following incubation, coverslips were washed three times with FA buffer
and once with distilled H2O, allowed to air dry, and inverted on microscope slides with fluorescence mounting medium. Cell
monolayers were examined with an Olympus BH2-RFCA fluorescence microscope equipped with 10× oculars, a dark-field condenser, and a
fluorescein filter. Samples were observed with a DPLANApo 40× UV
objective. Duplicate specimens were prepared for each test serum, and
approximately 100 macrophages in each of two randomly chosen fields
were counted for each coverslip. Coverslips were scored in a blinded
fashion, and data are expressed as the mean percentage of cells with
labeled inclusion bodies (internalized T. pallidum).
Statistical comparisons between groups were made by using a two-tailed
Student t test, with P values of
0.05
considered to be statistically significant. In some instances, the
association of fluorescently labeled treponemes with macrophages was
examined by confocal laser microscopy with an MRC-1024 laser confocal
imaging system (Bio-Rad). Specimens were imaged by using 10× oculars
with a 63× objective and 4× zoom. A series of 10 to 15 optical
sections (0.5 µm) through the macrophages were collected digitally
with a resolution of 0.076 µm per pixel.
Intradermal challenge of rabbits immunized with rGlpQ.
In the first challenge experiment, two rabbits were immunized with
rGlpQ as described above. Ten days after the second boost, the
rGlpQ-immunized and two serologically nonreactive control rabbits were
challenged with 104 virulent T. pallidum
organisms by intradermal injection on their shaved backs at each of six
sites. In a second challenge experiment, rabbits (four animals/group)
were immunized with rGlpQ or sham immunized. Ten days after the second
boost, they were challenged with 103 virulent T. pallidum organisms by intradermal injection on their shaved backs
at each of six sites. In both experiments animals were examined daily
to monitor the development, morphologic appearance, and progression of
lesions. Lesions were scored on the basis of erythema, induration, and
ulceration. Additionally, photographs were taken of the lesions to
document the extent of the reaction to challenge. At 17 days
postchallenge, two lesions from each rabbit were injected with 100 µl
of PBS, which was then aspirated for dark-field microscopy.
Radiolabeling of isolated T. pallidum outer
membranes with ([125I]TID).
Outer membranes
isolated from 1010 T. pallidum organisms as
previously described (54) were resuspended in cross-linking
buffer consisting of 0.01 M HEPES, 0.15 M NaCl, and 5 mM
MgCl2 (pH 7.5). After the addition of 5 µCi of
3-(trifluoromethyl)-3-(m-[125I]iodophenyl)-diazarene
([125I]TID) (Amersham, Arlington Heights, Ill.), the
sample was photoactivated by exposure for 30 min to long-wave (366-nm)
UV light. The sample was then pelleted in an Airfuge (Beckman, Palo
Alto, Calif.) and washed twice with cross-linking buffer prior to
SDS-PAGE and autoradiography.
 |
RESULTS AND DISCUSSION |
The T. pallidum GlpQ ortholog is a
lipoprotein.
We originally identified the T. pallidum GlpQ ortholog in OM fractions as a protein of
approximately 38 kDa (by SDS-PAGE) whose N terminus was blocked to
automated Edman degradation (56). Nucleotide sequence
analysis of the cloned glpQ gene provided a potential
explanation for this result; the encoded polypeptide possesses a
20-amino-acid signal peptide terminated by a putative lipoprotein
processing and modification site (L-V-A-G-C) (32, 56, 60).
We began the present study by conducting in vivo radiolabeling
experiments with [14C]palmitate to confirm that the
protein is indeed lipid modified. Although such studies are ideally
performed with T. pallidum, radiolabeling of
treponemal lipoproteins is complicated by the spirochete's
extremely slow rate of protein turnover (17).
Consequently, here, as in previous studies (1, 2, 45, 48),
we exploited the fact that lipid modification and processing signals
are highly conserved among eubacteria (47) and used E. coli as a T. pallidum surrogate for labeling
experiments. PhoA fusions are particularly advantageous for experiments
of this type because they tend to be well expressed in E. coli without toxicity, and they can be distinguished easily from
the large majority of native E. coli lipoproteins, which
migrate by SDS-PAGE with apparent molecular masses of well below 30 kDa
(the PhoA reporter has a molecular mass of 46.6 kDa) (1,
45). As shown in Fig. 1 (lane 3), a 49.5-kDa chimera in which the GlpQ ortholog's first 40 amino acids were fused to an unexported PhoA reporter was strongly radiolabeled with [14C]palmitate. PhoA fusions with Tp47
(64) and LacZ (1) served as positive and negative
controls (Fig. 1, lanes 1 and 2, respectively). Although these results
do not prove unequivocally that the native form of the protein is
similarly lipidated, we are unaware of any instances in which
spirochetal proteins were shown to be lipidated in E. coli but not in T. pallidum.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Lipid modification of GlpQ. E. coli
transformants harboring plasmids expressing PhoA fusions with the N
termini of Tp47 (lane 1), LacZ (lane 2), and GlpQ (lane 3) were
metabolically labeled with [14C]palmitate and then
analyzed by SDS-PAGE and autoradiography. All three polypeptides also
reacted with a monoclonal antibody specific for E. coli PhoA
(data not shown). Sizes of molecular mass standards in kilodaltons are
shown at the left.
|
|
General membrane topology of the native GlpQ ortholog.
We next used Triton X-114 phase partitioning (12, 15)
to assess the contribution of acylation to the amphiphilicity of nGlpQ; this method also served as a convenient starting point for
efforts to determine the protein's cellular location.
Percoll-purified T. pallidum, solubilized in 2% Triton
X-114 at 4°C, was phase partitioned, and the resulting fractions were
immunoblotted against pooled HSS or rat anti-rGlpQ antiserum. As
previously reported (52), the major lipoprotein
immunogens recognized by HSS are approximately equally distributed
between the detergent-enriched phase and the Triton X-114-insoluble
material, which contains the peptidoglycan sacculus (53). An
identical immunoblot probed with the anti-rGlpQ antiserum revealed
that nGlpQ was similarly distributed among the three fractions (Fig.
2B); we interpret these results as
indicating that a substantial portion of nGlpQ is intracellular, most
likely associated with the peptidoglycan-CM sacculus or its
constituents. In contrast to its native counterpart, rGlpQ partitioned
exclusively into the aqueous phase (Fig. 2C). Thus, as with other
treponemal lipoproteins (50), the amphiphilicity of
nGlpQ is not an intrinsic property of the polypeptide but rather is due
to lipid modification. This result also is in accord with the
prediction by hydropathy analysis that the GlpQ protein is extremely hydrophilic (56).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 2.
Amphiphilicity of native and recombinant GlpQ. (A and B)
T. pallidum was solubilized in 2% Triton X-114 in PBS
and phase partitioned as described in Materials and Methods. Whole
cells (WC), Triton X-114-insoluble material (I), the detergent-enriched
phase (D), and the aqueous phase (A) were subjected to immunoblot
analysis with 1:100 and 1:1,000 dilutions of HSS (A) or rat anti-rGlpQ
antiserum (B), respectively. (C) SDS-PAGE analysis and Coomassie blue
staining of rGlpQ after Triton X-114 phase partitioning. Sizes of
molecular mass standards in kilodaltons are shown on the left.
|
|
Evidence that nGlpQ is not surface exposed.
Spirochetal
lipoproteins consist of hydrophilic polypeptides which are lipid
anchored to membranes; because the protein components are extrinsic
to the lipid bilayer, they do not form particles when membranes are
subjected to freeze-fracture analysis (35, 51). Thus, even
if it is OM associated, it is unlikely that nGlpQ would be among the
rare proteins visualized in freeze-fractured T. pallidum OMs (49, 50, 62). On the other hand, the
studies thus far did not exclude the possibility that some nGlpQ is
exposed on the T. pallidum surface in a manner
analogous to the outer surface lipoproteins of the Lyme disease
spirochete Borrelia burgdorferi (7, 51). In fact,
B. burgdorferi is a particularly important precedent for the
studies here, because prior work has shown that portions of at least
three borrelial outer surface lipoproteins are CM anchored in
addition to being exposed on the bacterial surface (20). In
addressing this issue experimentally, it should be noted that surface
localization studies of T. pallidum are complicated by
a number of factors, most notably the lability of the treponemal OM and
the lack of antibodies against authentic OM proteins to serve as
positive controls (50). In light of these caveats and the
fact that biological and microscopy-based assays for surface
localization of treponemal antigens have not always correlated
(50), we used multiple approaches to determine whether nGlpQ
can be detected on the T. pallidum surface.
(i) Initially, we examined the accessibility of nGlpQ to
digestion with 0.4 mg of PK per ml, a method which has often been used
to identify surface-exposed antigens of B. burgdorferi (9, 42, 46). Consistent with the contention that
T. pallidum has a paucity of surface-exposed
proteins (22, 49, 50), only minor differences, none of
which were in the molecular weight range of nGlpQ, in the polypeptide
profiles of treponemes incubated with or without PK were observed (Fig.
3A). The most obvious difference, the
absence of the albumin band in the PK-treated organisms, confirmed that
the spirochetes were exposed to active enzyme. Immunoblot analysis of
the same samples did not reveal any obvious difference in the amounts
of nGlpQ (Fig. 3B). The surface specificity of the enzyme treatment was
confirmed by the observation that PK-treated and untreated organisms
contained similar amounts of the periplasmic markers Tp47 and TpEf
(Fig. 3B).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Inaccessibility of nGlpQ to PK digestion in intact
T. pallidum. (A) SDS-PAGE and silver staining of
T. pallidum incubated with (+) or without ( ) PK (0.4 mg/ml). The asterisk alongside the sample without PK designates
albumin. Sizes of molecular mass standards in kilodaltons are shown at
the left. (B) Immunoblot analysis of the same samples following
incubation with anti-rGlpQ ( rGlpQ), anti-TpEf, or anti-Tp47.
|
|
(ii) A second strategy involved immunofluorescence analysis
of spirochetes encapsulated in agarose beads (gel microdroplets) (20, 21). This method preserves the integrity of fragile
T. pallidum OMs during immunolabeling studies but also
enables the detection of intracellular antigens when organisms
are incubated with antibodies in the presence of a concentration
of Triton X-100 sufficient to permeabilize the OM (>0.03%). The bar
graphs in Fig. 4A depict the
combined results of three independent experiments. Intact
spirochetes did not fluoresce following incubation with an extremely
low (1:20) dilution of rat anti-rGlpQ antiserum. In separate immunoblot
experiments, this antiserum was capable of detecting nGlpQ in
whole-cell lysates at titers of greater than 1:10,000 (data not shown).
By contrast, nearly 100% of the organisms were labeled with this same
antiserum when the OMs were permeabilized with 0.05% Triton X-100.
Virtually identical results were obtained when the encapsulated
organisms were incubated with anti-TpEf in the absence or presence of
detergent. Qualitative differences in immunolabeling, on the other
hand, were observed with the anti-rGlpQ and anti-TpEf antisera. In
addition to being consistently less intense, the anti-rGlpQ antibodies
produced a beaded labeling pattern as opposed to the more uniform
labeling produced by anti-TpEf antibodies (Fig. 4B).


View larger version (107K):
[in this window]
[in a new window]
|
FIG. 4.
Localization of GlpQ in T. pallidum
encapsulated in gel microdroplets. (A) Encapsulated treponemes were
probed with pooled preimmune sera from rats immunized with rGlpQ, with
rat anti-rGlpQ antiserum ( rGlpQ), or with rabbit anti-TpEf antiserum
in the absence or presence of 0.05% Triton X-100. Labeling was
determined by comparing immunofluorescence with dark-field microscopy.
Each bar graph represents the mean ± standard deviation of
determinations (involving approximately 100 organisms) in three
separate experiments. Asterisks indicate statistically significant
results (P 0.05) compared to those with preimmune
sera. (B) Immunofluorescent labeling patterns of treponemes incubated
with anti-GlpQ or anti-TpEf antiserum in the absence or presence of
0.05% Triton X-100.
|
|
(iii) Stebeck and coworkers (60) identified GlpQ
as a potential opsonic target for T. pallidum by
differentially screening a genomic expression library with
opsonic and nonopsonic IRS. Although they did not directly determine
whether anti-GlpQ antibodies promote phagocytosis of motile treponemes
in their original communication, more recently this same group reported that antibodies against rGlpQ were not opsonic (16). Here we also undertook a comprehensive examination of the T. pallidum opsonic activity of anti-GlpQ antibodies. In comparison
with NRS, anti-TpEf, and anti-Tp47 negative controls, IRS significantly enhanced phagocytosis of motile treponemes, as previously reported (4-6, 38); no enhancement, on the other hand, was observed with anti-rGlpQ antiserum (Fig.
5A). To
rule out the possibility that the anti-GlpQ antibodies in IRS and the
anti-rGlpQ antisera are qualitatively different with respect to opsonic
activity, the assays were repeated with IRS from which anti-GlpQ
antibodies had been adsorbed. Preliminary immunoblot and enzyme-linked
immunosorbent assay studies confirmed that the adsorbed IRS contained
only trace amounts of anti-GlpQ antibodies (data not shown). In three
independent experiments, no significant differences in the opsonic
activities of IRS and the same IRS depleted of anti-nGlpQ antibodies
were observed (Fig. 5B). The affinity-purified anti-GlpQ antibodies by
themselves also failed to enhance opsonic activity (Fig. 5B). We also
considered the possibility that the trace amounts of residual anti-GlpQ
antibodies in the adsorbed IRS were still capable of contributing to
its opsonic activity. This possibility was excluded by observing that
serial dilutions of IRS and IRS lacking anti-GlpQ antibodies of as high
as 1:1,000 possessed essentially identical opsonic activities (Fig.
5C). As an additional control for these adsorption experiments, we also
investigated the opsonic activity of IRS depleted of total IgG. In
contrast to the results obtained when the IRS was depleted of anti-GlpQ
antibodies, IgG adsorption markedly diminished the serum's opsonic
activity, as previously noted (5), and this activity was
fully restored when the IgG antibodies were added back to the adsorbed
serum (Fig. 5B).



View larger version (64K):
[in this window]
[in a new window]
|
FIG. 5.
Anti-rGlpQ antiserum does not promote phagocytosis of
virulent T. pallidum by rabbit peritoneal macrophages.
(A) Opsonophagocytosis of virulent treponemes by rabbit peritoneal
macrophages 4 h after incubation of organisms in the presence of
10% heat-inactivated antisera. (B) Opsonic activity of anti-GlpQ
antibodies and total IgG affinity adsorbed from IRS. IRS- GlpQ, IRS
depleted of anti-GlpQ antibodies; GlpQ (IRS), anti-GlpQ antibodies
affinity purified from IRS; IRS-IgG, IRS depleted of total IgG
antibodies; IgG (IRS), affinity-purified total IgG antibodies from IRS;
(IRS-IgG)+IgG (IRS), IRS depleted of total IgG antibodies reconstituted
with affinity purified IgG. (C) Opsonic activity of serial dilutions of
IRS and IRS depleted of anti-GlpQ antibodies. In all panels, asterisks
indicate results which were significantly greater than those for NRS
controls. Results are means and standard errors.
|
|
As a sidelight to the present study, we noted an intriguing dichotomy
when macrophages incubated with treponemes with or without opsonic
antibodies were examined by confocal laser microscopy. Opsonized
treponemes were visualized almost exclusively as intracellular inclusions (Fig. 6B), representing
degraded organisms within lysosomal vacuoles (38),
whereas nonopsonized treponemes were visualized as intact organisms
bound to macrophage surfaces (Fig. 6A, C, and D). Even in the
absence of opsonizing antibodies, therefore, macrophages appear
to express receptors for surface-exposed treponemal ligands. Unlike
antibody-Fc receptor interactions, however, these receptor-ligand
interactions fail to trigger signaling pathways which promote bacterial
uptake. This observation underscores the notion that T. pallidum is an extracellular pathogen with little proclivity for
taking up residence within phagocytic cells and emphasizes as well the
treponeme's innate ability to avoid uptake and killing by macrophages.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 6.
Confocal laser microscopy of rabbit peritoneal
macrophages incubated with treponemes in the presence of opsonic or
nonopsonic antibodies. Serial optical sections through rabbit
peritoneal macrophages incubated with virulent treponemes in the
presence or absence of NRS (A), IRS (B), rabbit anti-rGlpQ antiserum
(C), or rabbit anti-TpEf antiserum (D) are shown. T. pallidum antigens were visualized by indirect immunofluorescence
with HSS.
|
|
(iv) Finally, we investigated whether immunization
with rGlpQ alters the course of infection in the rabbit model of experimental syphilis. Consistent with the above-described assays demonstrating a lack of surface exposure for nGlpQ, in two separate experiments involving a total of 12 rabbits, no differences in the time
course of lesion development and resolution, in gross lesion
appearance, or in the presence of treponemes in lesion aspirates from
GlpQ-immunized and control animals were observed (Fig.
7). This finding is in contrast to the
recent demonstration by Cameron et al. (16) of attenuated
lesion development when rGlpQ immunized rabbits were intradermally
challenged at each of six sites with 103 treponemes. This
modest degree of protective immunity probably reflects differences in
immunization protocols. It is also important to note that comparable
levels of partial protection have previously been observed following
immunization with T. pallidum proteins which are
known to be intracellular (13, 18, 65), most likely reflecting a cellular component in the protective immune response.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 7.
Immunization with rGlpQ does not protect rabbits against
experimental syphilis. Sham-immunized rabbits or rabbits immunized with
rGlpQ were challenged by intradermal inoculation at each of six sites
with 103 organisms. The photographs depict typical animals
in one of two separate experiments.
|
|
CD spectroscopic analysis of rGlpQ secondary structure.
Although the simplest interpretation of the above results was that
nGlpQ is not surface exposed, they also could have reflected a lack of
antibodies against conformational, surface-exposed epitopes in the
anti-rGlpQ antisera. Arguing against this was the observation from the
immunofluorescence studies that the antisera recognized native antigen
in organisms whose OMs were disrupted by mild detergent treatment.
Nevertheless, it was clearly desirable to learn more about the
recombinant protein's conformational state. Our initial efforts
along these lines were unsuccessful in that we were unable to detect
significant enzymatic activity in either recombinant E. coli whole-cell lysates or the purified polypeptide by using a variety of substrates. We then turned to CD spectroscopy as an
alternative means of examining the recombinant protein's secondary structure. Consistent with the secondary structures predicted by both
the Chou-Fasman (19) and Robson-Garnier (28)
algorithms (data not shown), the molar ellipticity values in the far-UV
region (195 to 260 nm) indicated that rGlpQ was predominantly
-helical. Equally important was the absence of discernible evidence
for denaturation (Table 1); admittedly,
we cannot rule out that more subtle structural abnormalities resulted
in the loss of enzymatic activity. As a control, we also examined the
CD spectrum of recombinant porin P1A from Neisseria
gonorrhoeae (3). As previously reported (3),
the gonococcal porin contains the relatively high degree of
-sheet
structure typical of a gram-negative bacterial outer membrane
protein (Table 1) (41).
Radiolabeling of isolated T. pallidum OMs with
([125I]TID).
Even with the above-described findings,
it was still possible that at least some nGlpQ was anchored via its
N-terminal lipids to the inner leaflet of the OM, similar to the case
for murein lipoprotein of E. coli (47). In
fact, this orientation could explain how the protein could be
present in isolated OMs but not surface exposed in intact treponemes.
To address this final question, we incubated isolated OMs with the
photoactivatable probe [125I]TID, an extremely lipophilic
reagent which promiscuously labels proteins and lipids within
the hydrophobic interiors of membranes (14, 33, 36).
Labeling with this reagent would indicate that the protein
was physically integrated into the OM bilayer rather than just
peripherally associated with it. As shown in Fig.
8, a single 30.5-kDa polypeptide
(designated p30.5 [gene TP0453] [27]) was
radiolabeled when isolated OMs were incubated with the photoactivatable
cross-linker. Two-dimensional gel electrophoresis confirmed that
this was the same protein as was recently identified in
T. pallidum whole cells incubated with this probe
(3). Two findings argue against the concern that this method
may not be sensitive enough to label low-abundance and/or
lipid-anchored integral OM proteins: (i) p30.5 is considerably less
abundant than nGlpQ (Fig. 8), and (ii) we recently have found that
p30.5 also is a lipoprotein (57). Furthermore, Everett
and Hatch (26) showed with Chlamydia trachomatis
that [125I]TID is capable of labeling bacterial
OM lipoproteins. Finally, we also considered the unlikely
possibility that nGlpQ detached from OMs during the fractionation
process. This was excluded by the finding that p30.5 was the only
protein labeled when motile treponemes were incubated with
[125I]TID prior to OM isolation (data not shown).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 8.
nGlpQ associated with T. pallidum OM
fractions is not radiolabeled by [125I]TID. Outer
membranes from 1010 treponemes were incubated with
[125I]TID prior to SDS-PAGE and then silver staining
(Ag) or autoradiography ([125I]TID). Labels to the
left of the silver-stained lane designate T. pallidum
proteins previously identified in isolated OMs. Numbers on the
right are molecular masses in kilodaltons.
|
|
Final topological assignment and conclusion.
The many
difficulties inherent in the molecular characterization of
T. pallidum OM proteins (50) have
spawned a variety of experimental approaches for accomplishing this
important but elusive objective (10, 11, 31, 54, 60). In
this regard, it is striking that two dissimilar strategies, OM
isolation (54) and differential genomic library screening to
identify potential T. pallidum opsonic targets
(60), yielded the same candidate OM protein, nGlpQ.
Nevertheless, the studies here present a substantial and consistent
body of evidence that nGlpQ is a periplasmic protein anchored
predominantly, if not exclusively, to the CM, thereby accounting for
its inability to induce a strongly protective immune response. Although
Cameron et al. (16) disagree with this conclusion, it is
consistent with their inability to detect opsonic activity in anti-GlpQ
antisera as well as their difficulty in obtaining additional evidence
for surface localization by other approaches, such as the gel
microdroplet assay. This assignment also agrees with the presumptive
physiological role of GlpQ in phospholipid metabolism and the fact that
it appears to be transcriptionally, and perhaps physiologically, linked
with the gene encoding phosphotidylglycerophosphate synthase, a
polytopic CM protein which mediates a key step in phospholipid
synthesis (27, 56). With this topology one can envision two
potential explanations for the protein's presence as a contaminant
in OM fractions (56) or its removal with OMs during
extensive washing of treponemes (16). The first is that one
or more domains of the nGlpQ polypeptide stably associate with the
OM's periplasmic leaflet. The second is that a portion of the
protein dissociates from the peptidoglycan-CM complex during the isolation procedure and becomes trapped within OM vesicles. While
these are not easily distinguished, we believe that the relatively low concentration of Triton X-100 needed for
complete immunolabeling of nGlpQ favors the former.
Two other outcomes of this study are noteworthy. The first concerns the
parallels between nGlpQ and another lipoprotein immunogen, Tpp17.
Both subsurface antigens are antibody accessible at relatively low
detergent concentrations, and both produce beaded labeling patterns
when lightly detergent-treated treponemes are incubated with
specific antibodies (21). The latter suggests that both proteins are nonuniformly distributed along the protoplasmic
cylinder. Additionally, both proteins are major constituents in
isolated OMs. Based upon its relative abundance in their OM
preparations, Blanco and coworkers (11) proposed that Tpp17
is lipid anchored to the OM inner leaflet. As with nGlpQ, the
[125I]TID labeling results, coupled with earlier results
from gel microdroplet studies (21), argue against this
topology. The second noteworthy outcome concerns the observation that
the p30.5 lipoprotein was the only protein identified when
isolated OMs or intact treponemes were subjected to radiolabeling with
[125I]TID. Several years ago, we proposed a model for
T. pallidum molecular architecture in which
lipoproteins are exclusively CM anchored (22). Although
its precise topology remains to be determined, the current data
indicate that p30.5 is likely to be an exception to this generalization.
 |
ACKNOWLEDGMENTS |
This research was supported in part by U.S. Public Health Service
grants AI-26756 and AI-38894 to J.D.R. T.J.S. was
supported by NRSA postdoctoral fellowship award AI-09973 and by a
research fellowship from the Arthritis Foundation.
 |
FOOTNOTES |
*
Corresponding author. Present address: Center for
Microbial Pathogenesis, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06030-3710. Phone: (860) 679-8129. Fax:
(860) 679-8130. E-mail: JRadolf{at}up.uchl.edu.
Editor:
P. E. Orndorff
 |
REFERENCES |
| 1.
|
Akins, D. R.,
S. F. Porcella,
T. G. Popova,
D. Shevchenko,
S. I. Baker,
M. Li,
M. V. Norgard, and J. D. Radolf.
1995.
Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homolog.
Mol. Microbiol.
18:507-520[Medline].
|
| 2.
|
Akins, D. R.,
B. K. Purcell,
M. Mitra,
M. V. Norgard, and J. D. Radolf.
1993.
Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity.
Infect. Immun.
61:1202-1210[Abstract/Free Full Text].
|
| 3.
|
Akins, D. R.,
E. Robinson,
D. V. Shevchenko,
C. Elkins,
D. L. Cox, and J. D. Radolf.
1997.
Tromp1, a putative rare outer membrane protein, is anchored by an uncleaved leader peptide to the Treponema pallidum cytoplasmic membrane.
J. Bacteriol.
179:576-586[Abstract/Free Full Text].
|
| 4.
|
Baker-Zander, S. A., and S. A. Lukehart.
1992.
Macrophage-mediated killing of opsonized Treponema pallidum.
J. Infect. Dis.
165:69-74[Medline].
|
| 5.
|
Baker-Zander, S. A.,
J. M. Shaffer, and S. A. Lukehart.
1993.
Characterization of the serum requirement for macrophage-mediated killing of Treponema pallidum ssp. pallidum: relationship to the development of opsonizing antibodies.
FEMS Immunol. Med. Microbiol.
6:273-279[Medline].
|
| 6.
|
Baker-Zander, S. A.,
J. M. Shaffer, and S. A. Lukehart.
1993.
VDRL antibodies enhance phagocytosis of Treponema pallidum by macrophages.
J. Infect. Dis.
167:1100-1105[Medline].
|
| 7.
|
Barbour, A. G., and S. F. Hayes.
1986.
Biology of Borrelia species.
Microbiol. Rev.
50:381-400[Free Full Text].
|
| 8.
|
Barbour, A. G.,
S. L. Tessier, and S. F. Hayes.
1984.
Variation in a major surface protein of Lyme disease spirochetes.
Infect. Immun.
45:94-100[Abstract/Free Full Text].
|
| 9.
|
Barbour, A. G.,
S. L. Tessier, and H. G. Stoenner.
1982.
Variable major proteins of Borrelia hermsii.
J. Exp. Med.
156:1312-1324[Abstract/Free Full Text].
|
| 10.
|
Blanco, D. R.,
M. Giladi,
C. I. Champion,
D. A. Haake,
G. K. Chikami,
J. N. Miller, and M. A. Lovett.
1991.
Identification of Treponema pallidum subspecies pallidum genes encoding signal peptides and membrane-spanning sequences using a novel alkaline phosphatase expression vector.
Mol. Microbiol.
5:2405-2415[Medline].
|
| 11.
|
Blanco, D. R.,
K. Reimann,
J. Skare,
C. I. Champion,
D. Foley,
M. M. Exner,
R. E. W. Hancock,
J. N. Miller, and J. N. Lovett.
1994.
Isolation of the outer membranes from Treponema pallidum and Treponema vincentii.
J. Bacteriol.
176:6088-6099[Abstract/Free Full Text].
|
| 12.
|
Bordier, C.
1981.
Phase separation of integral membrane proteins in Triton X-114 solution.
J. Biol. Chem.
256:1604-1607[Abstract/Free Full Text].
|
| 13.
|
Borenstein, L. A.,
J. D. Radolf,
T. E. Fehniger,
D. R. Blanco,
J. N. Miller, and M. A. Lovett.
1988.
Immunization with recombinant Treponema pallidum surface antigen 4D alters the course of experimental syphilis.
J. Immunol.
140:2415-2421[Abstract].
|
| 14.
|
Brunner, J.
1989.
Photochemical labeling of apolar phase of membranes.
Methods Enzymol.
172:628-687[Medline].
|
| 15.
|
Brusca, J. S., and J. D. Radolf.
1994.
Isolation of integral membrane proteins by phase partitioning with Triton X-114.
Methods Enzymol.
228:182-193[Medline].
|
| 16.
|
Cameron, C. E.,
C. Castro,
S. A. Lukehart, and W. C. Van Voorhis.
1998.
Function and protective capacity of Treponema pallidum subsp. pallidum glycerophosphodiester phosphodiesterase.
Infect. Immun.
66:5763-5770[Abstract/Free Full Text].
|
| 17.
|
Chamberlain, N. R.,
M. E. Brandt,
A. L. Erwin,
J. D. Radolf, and M. V. Norgard.
1989.
Major integral membrane protein immunogens of Treponema pallidum are proteolipids.
Infect. Immun.
57:2872-2877[Abstract/Free Full Text].
|
| 18.
|
Champion, C. I.,
J. N. Miller,
L. A. Borenstein,
M. A. Lovett, and D. R. Blanco.
1990.
Immunization with Treponema pallidum endoflagella alters the course of experimental rabbit syphilis.
Infect. Immun.
58:3158-3161[Abstract/Free Full Text].
|
| 19.
|
Chou, P. Y., and G. D. Fasman.
1978.
Prediction of the secondary structure of proteins from their amino acid sequence.
Adv. Enzymol.
47:45-148.
|
| 20.
|
Cox, D. L.,
D. R. Akins,
K. W. Bourell,
P. Lahdenne,
M. V. Norgard, and J. D. Radolf.
1996.
Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins.
Proc. Natl. Acad. Sci. USA
93:7973-7978[Abstract/Free Full Text].
|
| 21.
|
Cox, D. L.,
D. R. Akins,
S. F. Porcella,
M. V. Norgard, and J. D. Radolf.
1995.
Treponema pallidum in gel microdroplets: a novel strategy for investigation of treponemal molecular architecture.
Mol. Microbiol.
15:1151-1164[Medline].
|
| 22.
|
Cox, D. L.,
P. Chang,
A. McDowall, and J. D. Radolf.
1992.
The outer membrane, not a coat of host proteins, limits the antigenicity of virulent Treponema pallidum.
Infect. Immun.
60:1076-1083[Abstract/Free Full Text].
|
| 23.
|
Cox, D. L.,
B. Riley,
P. Chang,
S. Sayahtaheri,
S. Tassell, and J. Hevelone.
1990.
Effects of molecular oxygen, oxidation-reduction potential, and antioxidants upon in vitro replication of Treponema pallidum subsp. pallidum.
Appl. Environ. Microbiol.
56:3063-3072[Abstract/Free Full Text].
|
| 24.
|
Dickerson, M. C.,
J. Johnston,
T. E. Delea,
A. White, and E. Andrews.
1997.
The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria.
Sex. Transm. Dis.
23:429-440.
|
| 25.
|
Elkins, C.,
K. B. Barkley,
N. H. Carbonetti,
A. J. Coimbre, and P. F. Sparling.
1994.
Immunobiology of purified recombinant outer membrane porin protein I of Neisseria gonorrhoeae.
Mol. Microbiol.
14:1059-1075[Medline].
|
| 26.
|
Everett, K. D., and T. P. Hatch.
1995.
Architecture of the cell envelope of Chlamydia psittaci 6BC.
J. Bacteriol.
177:877-882[Abstract/Free Full Text].
|
| 27.
|
Fraser, C. M.,
S. J. Norris,
G. M. Weinstock,
O. White,
G. C. Sutton,
R. Dodson,
M. Gwinn,
E. K. Hickey,
R. Clayton,
K. A. Ketchum,
E. Sodergren,
J. M. Hardham,
M. P. McLeod,
S. Salzberg,
J. Peterson,
H. Khalak,
D. Richardson,
J. K. Howell,
M. Chidambaram,
T. Utterback,
L. McDonald,
P. Artiach,
C. Bowman,
M. D. Cotton,
C. Fujii,
S. Garland,
B. Hatch,
K. Horst,
K. Roberts,
M. Sandusky,
J. Weidman,
H. O. Smith, and J. C. Venter.
1998.
Complete genome sequence of Treponema pallidum, the syphilis spirochete.
Science
281:375-388[Abstract/Free Full Text].
|
| 28.
|
Garnier, J.,
D. J. Osguthorpe, and B. Robson.
1978.
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.
J. Mol. Biol.
120:97-120[Medline].
|
| 29.
|
Green, B. A.,
J. E. Farley,
T. Quinn-Dey,
R. A. Deich, and G. W. Zlotnick.
1991.
The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene.
Infect. Immun.
59:3191-3198[Abstract/Free Full Text].
|
| 30.
|
Hanff, P. A.,
S. J. Norris,
M. A. Lovett, and J. N. Miller.
1984.
Purification of Treponema pallidum, Nichols strain, by Percoll density gradient centrifugation.
Sex. Transm. Dis.
11:275-286[Medline].
|
| 31.
|
Hardham, J. M., and L. V. Stamm.
1994.
Identification and characterization of the Treponema pallidum tpn50 gene, an ompA homolog.
Infect. Immun.
62:1015-1025[Abstract/Free Full Text].
|
| 32.
|
Hayashi, S., and H. C. Wu.
1990.
Lipoproteins in bacteria.
J. Bioenerget Biomembr.
22:451-471[Medline].
|
| 33.
|
Hoppe, J.,
J. Brunner, and B. B. Jorgensen.
1984.
Structure of the membrane-embedded F0 part of F1F0 ATP synthase from Escherichia coli as inferred from labeling with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine.
Biochemistry
23:5610-5616[Medline].
|
| 34.
|
Isaacs, R. D.,
J. H. Hanke,
L.-M. Guzman-Verduzco,
G. Newport,
N. Agabian,
M. V. Norgard,
S. A. Lukehart, and J. D. Radolf.
1989.
Molecular cloning and DNA sequence analysis of the 37-kilodalton endoflagellar sheath protein of Treponema pallidum.
Infect. Immun.
57:3403-3411[Abstract/Free Full Text].
|
| 35.
|
Jones, J. D.,
K. W. Bourell,
M. V. Norgard, and J. D. Radolf.
1995.
Membrane topology of Borrelia burgdorferi and Treponema pallidum lipoproteins.
Infect. Immun.
63:2424-2434[Abstract].
|
| 36.
|
Jorgensen, P. L., and J. Brunner.
1983.
Labeling of intramembrane segments of the alpha-subunit and beta-subunit of pure membrane-bound (Na+ + K+)-ATPase with 3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine.
Biochim. Biophys. Acta
735:291-296[Medline].
|
| 37.
|
Larson, T. J.,
M. Ehrmann, and W. Boos.
1983.
Periplasmic glycerophosphodiester phosphodiesterase of Escherichia coli, a new enzyme of the glp regulon.
J. Biol. Chem.
258:5428-5432[Abstract/Free Full Text].
|
| 38.
|
Lukehart, S. A., and J. N. Miller.
1978.
Demonstration of the in vitro phagocytosis of Treponema pallidum by rabbit peritoneal macrophages.
J. Immunol.
121:2014-2024[Abstract/Free Full Text].
|
| 39.
|
Munson, R. S., Jr., and K. Sasaki.
1993.
Protein D, a putative immunoglobulin D-binding protein produced by Haemophilus influenzae, is glycerophosphodiester phosphodiesterase.
J. Bacteriol.
175:4569-4571[Abstract/Free Full Text].
|
| 40.
|
Nakashima, A. K.,
R. T. Rolfs,
M. L. Flock,
P. Kilmarx, and J. R. Greenspan.
1996.
Epidemiology of syphilis in the United States, 1941-1993.
Sex. Transm. Dis.
23:16-23[Medline].
|
| 41.
|
Nikaido, H.
1994.
Porins and specific diffusion channels in bacterial outer membranes.
J. Biol. Chem.
269:3905-3908[Free Full Text].
|
| 42.
|
Norris, S. J.,
C. J. Carter,
J. K. Howell, and A. G. Barbour.
1992.
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.
Infect. Immun.
60:4662-4672[Abstract/Free Full Text].
|
| 43.
|
O'Farrell, P. H.
1975.
High resolution two-dimensional electrophoresis of proteins.
J. Biol. Chem.
250:4007-4021[Abstract/Free Full Text].
|
| 44.
|
Perine, P. L.
1994.
Sexually transmitted diseases in the tropics.
Med. J. Aust.
160:358-363[Medline].
|
| 45.
|
Porcella, S. F.,
T. G. Popova,
D. R. Akins,
M. Li,
J. D. Radolf, and M. V. Norgard.
1996.
Borrelia burgdorferi supercoiled plasmids encode multiple tandem open reading frames and a lipoprotein gene family.
J. Bacteriol.
178:3293-3307[Abstract/Free Full Text].
|
| 46.
|
Probert, W. S.,
K. M. Allsup, and R. B. LeFebvre.
1995.
Identification and characterization of a surface-exposed 66-kilodalton protein from Borrelia burgdorferi.
Infect. Immun.
63:1933-1939[Abstract].
|
| 47.
|
Pugsley, A. P.
1993.
The complete general secretory pathway in gram-negative bacteria.
Microbiol. Rev.
57:50-108[Abstract/Free Full Text].
|
| 48.
|
Purcell, B. K.,
M. A. Swancutt, and J. D. Radolf.
1990.
Lipid modification of the 15 kilodalton major membrane immunogen of Treponema pallidum.
Mol. Microbiol.
4:1371-1379[Medline].
|
| 49.
|
Radolf, J. D.
1994.
Role of outer membrane architecture in immune evasion by Treponema pallidum and Borrelia burgdorferi.
Trends Microbiol.
2:307-311[Medline].
|
| 50.
|
Radolf, J. D.
1995.
Treponema pallidum and the quest for outer membrane proteins.
Mol. Microbiol.
16:1067-1073[Medline].
|
| 51.
|
Radolf, J. D.,
K. W. Bourell,
D. R. Akins,
J. S. Brusca, and M. V. Norgard.
1994.
Analysis of Borrelia burgdorferi membrane architecture by freeze-fracture electron microscopy.
J. Bacteriol.
176:21-31[Abstract/Free Full Text].
|
| 52.
|
Radolf, J. D.,
N. R. Chamberlain,
A. Clausell, and M. V. Norgard.
1988.
Identification and localization of integral membrane proteins of Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent Triton X-114.
Infect. Immun.
56:490-498[Abstract/Free Full Text].
|
| 53.
|
Radolf, J. D.,
C. Moomaw,
C. A. Slaughter, and M. V. Norgard.
1989.
Penicillin-binding proteins and peptidoglycan of Treponema pallidum subsp. pallidum.
Infect. Immun.
57:1248-1254[Abstract/Free Full Text].
|
| 54.
|
Radolf, J. D.,
E. J. Robinson,
K. W. Bourell,
D. R. Akins,
S. F. Porcella,
L. M. Weigel,
J. D. Jones, and M. V. Norgard.
1995.
Characterization of outer membranes isolated from Treponema pallidum, the syphilis spirochete.
Infect. Immun.
63:4244-4252[Abstract].
|
| 55.
|
Ruan, M. R.,
M. Akkoyunlu,
A. Grubb, and A. Forsgren.
1990.
Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD.
J. Immunol.
145:3379-3384[Abstract].
|
| 56.
|
Shevchenko, D. V.,
D. R. Akins,
E. J. Robinson,
M. Li,
O. V. Shevchenko, and J. D. Radolf.
1997.
Identification of homologs for thioredoxin, peptidyl prolyl cis-trans isomerase, and glycerophosphodiester phosphodiesterase in outer membrane fractions from Treponema pallidum, the syphilis spirochete.
Infect. Immun.
67:4179-4189.
|
| 57.
| Shevchenko, D. V., D. R. Akins, E. J. Robinson, and J. D. Radolf. 1998. Unpublished observations.
|
| 58.
|
Sreerama, N., and R. W. Woody.
1996.
A self-consistent method for the analysis of protein secondary structure from circular dichroism.
Anal. Biochem.
209:32-44.
|
| 59.
|
Sreerama, N., and R. W. Woody.
1994.
Poly(Pro)II helices in globular proteins: identification and circular dichroic analysis.
Biochemistry
33:10022-10025[Medline].
|
| 60.
|
Stebeck, C. E.,
J. M. Shaffer,
T. W. Arroll,
S. A. Lukehart, and W. C. Van Voorhis.
1997.
Identification of the Treponema pallidum susp. pallidum glycerophosphodiester phosphodiesterase homologue.
FEMS Microbiol. Lett.
154:303-310[Medline].
|
| 61.
|
Tramont, E. C.
1994.
Treponema pallidum (syphilis), p. 2117-2133.
In
G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, Inc., New York, N.Y.
|
| 62.
|
Walker, E. M.,
G. A. Zampighi,
D. R. Blanco,
J. N. Miller, and M. A. Lovett.
1989.
Demonstration of rare protein in the outer membrane of Treponema pallidum subsp. pallidum by freeze-fracture analysis.
J. Bacteriol.
171:5005-5011[Abstract/Free Full Text].
|
| 63.
|
Wasserheit, J. N.
1992.
Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases.
Sex. Transm. Dis.
19:61-77[Medline].
|
| 64.
|
Weigel, L. M.,
J. D. Radolf, and M. V. Norgard.
1994.
The 47-kDa major lipoprotein immunogen of Treponema pallidum is a penicillin-binding protein with carboxypeptidase activity.
Proc. Natl. Acad. Sci. USA
91:11611-11615[Abstract/Free Full Text].
|
| 65.
|
Wicher, K.,
L. M. Schouls,
V. Wicher,
J. D. Van Embden, and S. S. Nakeeb.
1991.
Immunization of guinea pigs with recombinant TmpB antigen induces protection against challenge infection with Treponema pallidum Nichols.
Infect. Immun.
59:4343-4348[Abstract/Free Full Text].
|
Infection and Immunity, May 1999, p. 2266-2276, Vol. 67, No. 5
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Brinkman, M. B., McKevitt, M., McLoughlin, M., Perez, C., Howell, J., Weinstock, G. M., Norris, S. J., Palzkill, T.
(2006). Reactivity of Antibodies from Syphilis Patients to a Protein Array Representing the Treponema pallidum Proteome.. J. Clin. Microbiol.
44: 888-891
[Abstract]
[Full Text]
-
LaFond, R. E., Lukehart, S. A.
(2006). Biological Basis for Syphilis. Clin. Microbiol. Rev.
19: 29-49
[Abstract]
[Full Text]
-
Hazlett, K. R. O., Cox, D. L., Decaffmeyer, M., Bennett, M. P., Desrosiers, D. C., La Vake, C. J., La Vake, M. E., Bourell, K. W., Robinson, E. J., Brasseur, R., Radolf, J. D.
(2005). TP0453, a Concealed Outer Membrane Protein of Treponema pallidum, Enhances Membrane Permeability. J. Bacteriol.
187: 6499-6508
[Abstract]
[Full Text]
-
Champion, C. I., Blanco, D. R., Lovett, M. A.
(2005). Quantitative Assessment of Protection in Experimental Syphilis. Infect. Immun.
73: 5923-5927
[Abstract]
[Full Text]
-
Van Voorhis, W. C., Barrett, L. K., Lukehart, S. A., Schmidt, B., Schriefer, M., Cameron, C. E.
(2003). Serodiagnosis of Syphilis: Antibodies to Recombinant Tp0453, Tp92, and Gpd Proteins Are Sensitive and Specific Indicators of Infection by Treponema pallidum. J. Clin. Microbiol.
41: 3668-3674
[Abstract]
[Full Text]